Fortem Financial Group, LLC Abbott Laboratories Transaction History

Fortem Financial Group, LLC

$240 Million
Q3 2024

A detailed history of Fortem Financial Group, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Fortem Financial Group, LLC holds 7,994 shares of ABT stock, worth $926,504. This represents 0.38% of its overall portfolio holdings.

Number of Shares

7,994

Previous 7,754 3.1%

Holding current value

$926,504

Previous $805,000 13.17%

% of portfolio

0.38%

Previous 0.36%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$100.07 - $118.13 $24,016 - $28,351	240 Added 3.1%	7,994 $911,000
Q2 2024 Aug 02, 2024	BUY	$100.73 - $112.44 $26,794 - $29,909	266 Added 3.55%	7,754 $805,000
Q1 2024 May 01, 2024	BUY	$109.52 - $120.96 $57,826 - $63,866	528 Added 7.59%	7,488 $851,000
Q4 2023 Jan 25, 2024	SELL	$90.19 - $110.4 $57,270 - $70,104	-635 Reduced 8.36%	6,960 $766,000
Q3 2023 Oct 10, 2023	SELL	$95.53 - $114.62 $166,986 - $200,355	-1,748 Reduced 18.71%	7,595 $735,000
Q2 2023 Jul 18, 2023	BUY	$100.78 - $112.29 $116,703 - $130,031	1,158 Added 14.15%	9,343 $1.02 Million
Q1 2023 Apr 21, 2023	SELL	$96.86 - $114.01 $126,014 - $148,327	-1,301 Reduced 13.71%	8,185 $828,000
Q4 2022 Jan 17, 2023	SELL	$95.06 - $111.52 $92,683 - $108,732	-975 Reduced 9.32%	9,486 $0
Q3 2022 Nov 01, 2022	BUY	$96.76 - $112.03 $28,640 - $33,160	296 Added 2.91%	10,461 $1.01 Million
Q2 2022 Jul 25, 2022	SELL	$102.07 - $123.37 $260,584 - $314,963	-2,553 Reduced 20.07%	10,165 $1.1 Million
Q1 2022 Apr 27, 2022	BUY	$114.02 - $139.04 $203,867 - $248,603	1,788 Added 16.36%	12,718 $1.51 Million
Q4 2021 Jan 20, 2022	BUY	$115.53 - $141.46 $27,611 - $33,808	239 Added 2.24%	10,930 $1.54 Million
Q3 2021 Oct 15, 2021	BUY	$116.66 - $129.06 $15,982 - $17,681	137 Added 1.3%	10,691 $1.26 Million
Q2 2021 Jul 14, 2021	BUY	$105.79 - $124.53 $121,870 - $143,458	1,152 Added 12.25%	10,554 $1.22 Million
Q1 2021 Apr 20, 2021	SELL	$108.84 - $128.23 $2,612 - $3,077	-24 Reduced 0.25%	9,402 $1.13 Million
Q4 2020 Jan 29, 2021	SELL	$105.0 - $114.42 $22,890 - $24,943	-218 Reduced 2.26%	9,426 $1.03 Million
Q3 2020 Oct 15, 2020	BUY	$91.64 - $111.29 $268,321 - $325,857	2,928 Added 43.6%	9,644 $1.05 Million
Q2 2020 Jul 14, 2020	SELL	$76.57 - $98.0 $149,847 - $191,786	-1,957 Reduced 22.56%	6,716 $614,000
Q1 2020 Apr 23, 2020	SELL	$62.82 - $91.86 $67,028 - $98,014	-1,067 Reduced 10.95%	8,673 $684,000
Q4 2019 Feb 11, 2020	BUY	$78.51 - $87.4 $160,709 - $178,907	2,047 Added 26.61%	9,740 $846,000
Q3 2019 Nov 12, 2019	BUY	$81.84 - $88.74 $371,389 - $402,702	4,538 Added 143.84%	7,693 $644,000
Q2 2019 Aug 09, 2019	BUY	$72.88 - $85.0 $29,807 - $34,765	409 Added 14.89%	3,155 $265,000
Q1 2019 May 13, 2019	BUY	$66.22 - $80.06 $181,840 - $219,844	2,746 New	2,746 $220,000

Others Institutions Holding ABT

# of Institutions

3,187

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fortem Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fortem Financial Group, LLC with notifications on news.

Account

Fortem Financial Group, LLC Abbott Laboratories Transaction History